Analyst ratings, especially from a reputable financial institution like Citigroup, can significantly influence investor sentiment and stock prices. A Buy rating combined with a high price target suggests a strong bullish outlook for Madrigal Pharmaceuticals, potentially leading to increased investor interest and a rise in stock price in the short term.